U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 137

Tests names and labsConditionsGenes, analytes, and microbesMethods

MODY and Neonatal Diabetes Panel, Sequencing

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
1723
  • C Sequence analysis of the entire coding region

Invitae Monogenic Diabetes Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
5928
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Monogenic Diabetes Panel

PreventionGenetics, part of Exact Sciences
United States
10154
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hypoglycemia Panel

PreventionGenetics, part of Exact Sciences
United States
217171
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hyperinsulinemic hypoglycemia, familial, 3, 602485, Autosomal dominant; HHF3 (Hyperinsulinism due to glucokinase deficiency) (Prenatal) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Hyperinsulinemic hypoglycemia, familial, 3, 602485, Autosomal dominant; HHF3 (Hyperinsulinism due to glucokinase deficiency) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Hyperinsulinemic hypoglycemia, familial, 3, 602485, Autosomal dominant; HHF3 (Hyperinsulinism due to glucokinase deficiency) (GCK gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Hyperinsulinemic hypoglycemia, familial, 3, 602485, Autosomal dominant; HHF3 (Hyperinsulinism due to glucokinase deficiency) (GCK gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

MODY, type II, 125851, Autosomal dominant; MODY2 (MODY) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

MODY, type II, 125851, Autosomal dominant; MODY2 (MODY) (GCK gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Diabetes mellitus, noninsulin-dependent, late onset, 125853, Autosomal dominant (GCK gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Diabetes mellitus, noninsulin-dependent, late onset, 125853, Autosomal dominant (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Diabetes mellitus, permanent neonatal, 606176, Autosomal dominant (Permanent neonatal diabetes mellitus) (GCK gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Diabetes mellitus, permanent neonatal, 606176, Autosomal dominant (Permanent neonatal diabetes mellitus) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

WES metabolic disorders

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
1625
  • E Sequence analysis of select exons

Maturity-Onset Diabetes of the Young (MODY) Panel

Ambry Genetics
United States
145
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Level 2: Expanded Congenital Hyperinsulinism Panel

Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine
United States
76
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region

Level 1: Congenital Hyperinsulinisim Panel

Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine
United States
53
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Congenital Hyperinsulinism Panel

PreventionGenetics, part of Exact Sciences
United States
99
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Maturity Onset Diabetes of the Young (MODY) Panel

PreventionGenetics, part of Exact Sciences
United States
2018
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 21 to 40 of 137

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.